Goldman Sachs upgraded BioNTech (BNTX) to Buy from Neutral with a price target of $137, up from $90. The firm upgrade the shares after ...

In a report released yesterday, Chris Shibutani from Goldman Sachs upgraded BioNTech SE (BNTX – Research Report) to a Buy, with a price ...

BioNTech SE reported a surprise profit in the third quarter, helped by solid sales of its variant-adapted Covid-19 vaccines. Mainz, Germany-based BioNTech posted earnings of €0.81 ($0.88) per ...

offers an upscale take on the tee featuring a bold logo across the front. Made with organic cotton jersey, their best T-shirt for men comes in seven colorways, including an eye-catching vivid blue ...

Since 2019, we’ve tested over 50 shirts, rigorously evaluating their ... a reliable crowd-pleaser; a luxury-logo classic; a splurge-worthy button-down with special details; and a slim, budget ...

In 2021, with the COVID-19 pandemic in full swing, BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) were the darlings of the pharma and biotech worlds. The two mRNA therapy developers created ...

At a press conference in May, Tyson gave a questionable response to Paul trolling him that left people shocked. Paul ...

The FDA has implemented a partial hold on a phase 3 non-small cell lung cancer trial run by BioNTech and OncoC4 after seeing varying results among patients. The hold impacts an open-label trial ...

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

(RTTNews) - Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a net profit of 198.1 million euros or 0.81 euros per share for the third quarter ...

As part of a restructuring of the Chrysler LLC group in 2010, one of the most significant changes was made to the brand's logo, which remains the latest in a long list of modifications since its ...